zadnja posodobitev :
22/08/2024
Infostab
Seznami
Seznami
Poiščite združljivosti
Tabela združljivosti Y-strani
Viri
raziskovalne skupine
valistab
poster
Povezave
sponzorji
Avtor
Navodilo za uporabo
Newsletter
Meropenem
Kemična formula
Lastniško ime
Sestava pomožnih snovi je med paralelami lahko različna
Acus
Čile
Amplium
Mehika
Anfletec
Argentina
Bapentor
Mehika
Biomerem
Venezuela
Klopenem
Argentina
Mectinex
Čile
Meprim
Čile
Merinfec
Avstrija
Merobac
Ekvador, Kolumbija, Peru
Meromax
Čile
Meronem
Belgija, Čile, Danska, Ekvador, Finska, Grčija, Hrvaška, Irska, Islandija, Južnoafriška republika, Kolumbija, Luksemburg, Madžarska, Nemčija, Nizozemska, Norveška, Peru, Poljska, Portugalska, Romunija, Savdska Arabija, Slovenija, Španija, Švedska, Švica, Tajska, Turčija, Velika Britanija, Združeni arabski emirati
Meropen
Japonska
Merozan
Grčija
Merozem
Argentina
Merpem
Argentina
Merrem
Francija, Italija, Kanada
Optinem
Avstrija
Viri : Meropenem
Tip
objava
10
časopis
Patel PR, Cook SE.
Stability of meropenem in intravenous solutions.
Am J Health-Syst Pharm 1997 ; 54: 412-421.
266
časopis
Patel PR.
Compatibility of meropenem with commonly used injectable drugs.
Am J Health-Syst Pharm 1996 ; 53: 2853-2855.
1275
časopis
Walker SE, Varrin S, Yannicelli D, Law S.
Stability of meropenem in saline and dextrose solutions and compatibility with potassium chloride.
Can J Hosp Pharm 1998 ; 51: 156-168.
1415
časopis
Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
JPEN 1999 ; 23: 67-74.
1454
časopis
Grant EM, Zhong MK, Ambrose PG, Nicolau DP, Nightingale CH, Quiniliani R.
Stability of meropenem in a portable infusion device in a cold pouch.
Am J Health-Syst Pharm 2000 ; 57: 992-995.
1508
časopis
Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F.
Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU.
EJHP 2015 ;22:123-124.
1639
časopis
Krämer I.
Stability of meropenem in elastomeric portable infusion devices.
Eur Hosp Pharm 1997 ; 3: 168-171.
1754
časopis
Trissel LA, Gilbert DL, Wolkin AC.
Compatibility of docetaxel with selected drugs during simulated Y-site administration.
Int J Pharm Compound 1999 ; 3: 241-244.
1925
časopis
Trissel LA , Williams KY, Gilbert DL.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
J Am Pharm Assoc 2000 ; 40: 515-519.
1942
časopis
Smith DL, Bauer SM, Nicolau DP.
Stability of meropenem in polyvinyl chloride bags and an elastomeric infusion device.
Am J Health-Syst Pharm 2004 ; 61: 1682-1685.
1982
časopis
Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2017
časopis
Barker B, Feddema S, Rusho WJ, Dengg R.
Visual compatibility of vasopressin with other injectable drugs.
Am J Health-Syst Pharm 2005 ; 62: 1969-1976.
2042
časopis
Viaene E, Chanteux H, Servais H, Mingeot-Leclerq MP, Tulkens PM.
Comparative stability studies of antipseudomonal ß-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).
Antimicrob Agents Chemother 2002 ; 46: 2327-2332.
2090
časopis
Pere H, Chasse V, Forest JM, Hildgen P.
Compatibility of injectable pantoprazole in Y-site administration.
Pharmactuel 2004 ; 37: 193-196.
2109
časopis
Pelletier E, Forest JM, Hildgen P.
Compatibilité de la kétamine injectable lors de l’administration en dérivé avec d’autres médicaments usuels.
Pharmactuel 2006 ; 39: 71-75.
2120
časopis
Mendez A.S.L, Dalomo J, Steppe M; Schapoval E.E.S.
Stability and degradation kinetics of meropenem in powder for injection and reconstituted sample.
J Pharm Biomed Anal 2006 ; 41: 1363-1366.
2231
časopis
de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2233
časopis
Condie C.K, Tyler L.S, Barker B, Canann D.M.
Visual compatibility of caspofungin acetate with commonly used drugs during simulated Y-site delivery
Am J Health-Syst Pharm 2008 ; 65, 5: 454-457.
2247
časopis
Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
2335
časopis
Canann D, Tyler L.S, Barker B, Condie C.
Visual compatibility of i.v. medications routinely used in bone marrow transplant recipients
Am J Health-Syst Pharm 2009 ; 66, 8: 727-729
2793
časopis
Tomasello C, Leggieri A, Cavalli R, Di Perri G, D?Avolio A.
In Vitro Stability Evaluation of Different Pharmaceutical Products Containing Meropenem.
Hosp Pharm 2015 ; 50, 4 : 296-303.
3012
časopis
Sullivan T, Forrest J.M, Leclair G.
Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration
Hosp Pharm 2015 ; 50, 3: 214-220.
3112
časopis
Berthoin K, Le Duff, CS , Marchand-Brynaert J, Carryn S, Tulkens PM
Stability of meropenem and doripenem solutions for administration by continuous infusion
J Antimicrob Chemother 2010 ; 65: 1073-1075
3152
časopis
Kumar A, Mann HJ.
Visual compatibility of oritavancin diphosphate with selected coadministered drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2010 ; 67: 1640-1644.
3216
časopis
Legris ME, Valiquette ME, Lavoie A, Forest JM, Leclair G.
Compatibilité physique par évaluation visuelle du salbutamol injectable lors de son administration en Y.
Pharmactuel 2011 ; 44, 1 : 14-18
3254
časopis
Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3408
časopis
Tollec S, Touzin K, Pelletier E, Forest J.M.
Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels.
Pharmactuel 2013 ; 46, 1 : 16-21.
3475
časopis
Chen L.Y, Chen J, Waters V, Boodhan S.
Incompatibility of ciprofloxacin and meropenem injections.
Am J Health-Syst Pharm 2013 ;70:1966-1970.
3549
Traduction Laboratorij
Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3595
Traduction Laboratorij
Aciclovir - Summary of Product Characteristics
Hospira 2009
3674
Traduction Laboratorij
Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3767
časopis
Legris M.E, Lavoie A, Forrest J.M, Hildgen P.
Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels.
Pharmactuel 2014 ; 47, 3 : 167-172.
3824
časopis
Boudi S, Roy H, Forest JM, Leclair G.
Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y.
Pharmactuel 2023 2023;56,3:91-98
3827
poster
Ghazi I.M, Hamada Y, Nicolau D.P.
Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
ASHP Midyear 2015
3828
poster
Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829
poster
So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
3837
časopis
Jaruratanasirikul S, Sriwiriyajan S.
Stability of meropenem in normal saline solution after storage at room temperature.
South Asian J Trop Med Pub Health 2003 ; 34: 627-629.
3879
časopis
Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace Edward E.
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
Int J Pharm Compound 2016 ; 20, 4 : 328-332.
3922
časopis
Wiesholzer, Winter A, Kussmann M, Zeitlinger M, Pichler P, Burgmann H, Reznicek G,Poepp l W.
Compatibility of meropenem with different commercial dialysis solutions.
Perit Dial Int 2016 doi:10.3747/pdi.2016.0001
3948
časopis
Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P .
Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation.
JPEN 2012 ;30. 416?424.
3964
časopis
Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G.
Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments.
Pharmactuel 2017 ; 50,1 : 27-33.
3976
časopis
Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
3997
časopis
Katip W.
Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74:14 : 1099-1102
4055
časopis
Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44
4122
časopis
Fawaz S, Barton S, Whitney L, Swinden J, Nabhani-Gebara S.
Stability of Meropenem After Reconstitution for Administration by Prolonged Infusion.
Hosp Pharm 2018 ;54,3:190?196
4145
časopis
Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P.
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4147
časopis
Carlier M, Stove V, Verstraete A.G, De Waele J.J.
Stability of generic brands of meropenem reconstituted in isotonic saline.
Minerva Anestesiologica 2014 ;81,3:283-287
4180
časopis
Mendes K, Harmanjeet H, Sedeeq M, Modi A, Wanandy T, Zaidi S, Ming L, Castelino R, Sud K, Peterson G, Patel R.
Stability of meropenem and piperacillin/tazobactam with heparin in various peritoneal dialysis solutions.
Perit Dial Int 2018 ;38,6:430-440
4290
časopis
Venugopalan V, Manigaba K, Borgert S.J, Cope J, Peloquin C.A, Klinker K.P.
Training a Drug to Do New Tricks: Insights on Stability of Meropenem Administered as a Continuous Infusion.
Microbiology Insights 2018 ; 11, 1-6
4319
časopis
Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4326
časopis
Curti C, Harti Souab K, Lamy E, Mathias F, Bornet C, Guinard B, Fersing C, Primas N, Albanèse J, Vanelle P.
Stability studies of antipyocyanic beta-lactam antibiotics used in continuous infusion.
Pharmazie 2019 ; 74: 357-362.
4380
Traduction Laboratorij
Posaconazole (Noxafil®) - Summary of Product Characteristics
Merck Sharp & Dohme Limited 2019
4389
časopis
Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Pharmactuel 2019 ;52,4:206-213
4403
časopis
De Souza Barbosa F, Capra Pezzi L, Tsao M, Manoela Dias Macedo S, Franco de Oliveira T, Schapoval EES, Mendez ASL.
Stability in clinical use and stress testing of meropenem antibiotic by direct infusion ESI-Q-TOF: Quantitative method and identification of degradation products.
J Pharm Biomed Anal 2020 ; 179: 112973.
4405
časopis
Ezquer-Garin C, Ferriols-Lisart R, Martinez-López LM, Sangrador-Pelluz C, Nicolás-Picó J, Alós-Almiñana M.
Stability of tedizolid phosphate-sodium rifampicin and tedizolid phosphate-meropenem admixtures in intravenous infusion bags stored at different temperatures
Pharmazie 2020 ; 75: 172-176.
4434
časopis
Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L.
Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
Clin Ther 2019 ; 41, 10: 2162-2170.
4440
časopis
Omotani S, Aoe M, Esaki S, Nagai K, Hatsuda Y, Mukai J, Teramachi H, Myotoku M.
Compatibility of Intravenous Fat Emulsion with Antibiotics for Secondary Piggyback Infusion.
Ann Nutr Metab 2018 ; 73: 227-233.
4465
časopis
Foushee A, Meredith P, Fox Laura, Wilder A.
Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients.
Am J Health-Syst Pharm 2020 ;77,14:1144-1148
4470
časopis
Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P.
Continuous versus intermittent infusion of temocillin in intensive care unit patient.
Critical care 2005 ; 9(Suppl 1) P37
4528
časopis
Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Int J Pharm Compound 2021 ;25,1:52-61
4543
časopis
Senarathna G, Strunk T, Petrovski M, Batty K.
Physical compatibility of pentoxifylline and intravenous medications.
Archives of Disease in Childhood 2018 ;104:292–295.
4572
časopis
Gostynska A, Piwowarczyk L, Nadolna M, Jelinska A, Dettlaff K, Ogrodowczyk M, Popielarz-Brzezinska M, Stawny M.
Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures.
Antibiotics 2021 ; 10, 217.
4592
časopis
Liebchen U, Rakete S, Vogeser M, Arend F.M, Kinast C, Scharf C, Zoller M, Schönermarck U, Paal M.
The Role of Non-Enzymatic Degradation of Meropenem—Insights from the Bottle to the Body.
Antibiotics 2021 ; 10: 715.
4603
časopis
Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G.
Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.
Hosp Pharm 2021 ; 56, 4: 228-234.
4634
časopis
Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A.
Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy.
Antibiotics 2022 ;11,4: 458
4654
poster
Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R.
Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables.
Communication personnelle 2021
4742
časopis
Macoviciuc M, Nguyen C, Forest J-M, Leclair G.
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y.
Pharmactuel 2022 ; 55, 4: 247-255.
4801
časopis
Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J.
Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2024 ;51,1:
Mentions Légales